TITLE

Comment on "Sublingual capnometry tracks microcirculatory changes in septic patients" by Creteur et al

AUTHOR(S)
Hasibeder, Walter; Knotzer, Hans; Friesenecker, Barbara; Dünser, Martin; Dünser, Martin
PUB. DATE
October 2006
SOURCE
Intensive Care Medicine;Oct2006, Vol. 32 Issue 10, p1665
SOURCE TYPE
Academic Journal
DOC. TYPE
commentary
ABSTRACT
A letter to the editor is presented about a study on sublingual capnometry tracks microcirculatory changes in septic patients.
ACCESSION #
22530359

 

Related Articles

  • Safety of Long-Acting Beta-Agonists. O'Connor, George T. // New England Journal of Medicine;3/16/2006, Vol. 354 Issue 11, p1206 

    A letter to the editor is presented in response to a study on the suggestions that long-acting beta-agonists may contribute to deaths from asthma by researcher Fernando D. Martinez in the December 22, 2005 issue.

  • Safety of Long-Acting Beta-Agonists. Martinez, Fernando D. // New England Journal of Medicine;3/16/2006, Vol. 354 Issue 11, p1206 

    A response by researcher Fernando D. Martinez to letters to the editor about his article on the safety of long-acting beta-agonists in the December 22, 2005 issue is presented.

  • Beta2 Agonists in the Treatment of Asthma. Yawn, Barbara // American Family Physician;7/15/2006, Vol. 74 Issue 2, p232 

    A letter to the editor is presented about the use of long-acting beta2 agonists for the treatment of asthma.

  • Effects of Anticholinergics and β-agonists in COPD. Hansen-Flaschen, John // JGIM: Journal of General Internal Medicine;Jun2007, Vol. 22 Issue 6, p893 

    A letter to the editor is presented in response to an article about the association between maintenance use of inhaled β2-agonists for chronic obstructive pulmonary disease and increased risk of respiratory death.

  • Author Reply. Salpeter, Shelley R. // JGIM: Journal of General Internal Medicine;Jun2007, Vol. 22 Issue 6, p894 

    A letter to the editor is presented in response to comments made on the author's article about the association between maintenance use of inhaled β2-agonists for chronic obstructive pulmonary disease and increased risk of respiratory death.

  • Author's response. Weatherall, Mark // Thorax;Jun2011, Vol. 66 Issue 6, p542 

    A response by Mark Weatherwall to a letter to the editor in raising interesting and pertinent point in identifying patients at risk of β-agonist toxicity.

  • Adding LABAs to Inhaled Glucocorticoids for Asthma.  // New England Journal of Medicine;9/29/2011, Vol. 365 Issue 13, p1260 

    A letter to the editor is presented in response to an article about long-acting beta-agonists (LABAs), by Chowdhury and colleagues, published in the June 30, 2011 issue.

  • Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. Hernandez, Glenn; Bruhn, Alejandro; Luengo, Cecilia; Regueira, Tomas; Kattan, Eduardo; Fuentealba, Andrea; Florez, Jorge; Castro, Ricardo; Aquevedo, Andres; Pairumani, Ronald; McNab, Paul; Ince, Can // Intensive Care Medicine;Aug2013, Vol. 39 Issue 8, p1435 

    Purpose: The role of dobutamine during septic shock resuscitation is still controversial since most clinical studies have been uncontrolled and no physiological study has unequivocally demonstrated a beneficial effect on tissue perfusion. Our objective was to determine the potential benefits of...

  • β-agonist safety and the elephant in the room? Williamson, P. A.; Short, P. M.; McKinlay,, L.; Palmer, C. N. A.; Lipworth, B. J. // Thorax;Jun2011, Vol. 66 Issue 6, p542 

    A letter to the editor is presented in response to the article by Mark Weatherwall regarding the result of a meta-analysis on the relative safety of long-acting β-agonists (LABA).

  • The Journal Club.  // Indian Journal of Pharmacology;Aug2010, Vol. 42 Issue 4, p257 

    The article presents updates related to the various pharmacological studies and clinical trials. It mentions the occurrence of the brain natriuretic peptide (BNP) in the integration of stroke and hypertension in human. It cites the effectiveness of norepinephrine in treating dopamine-resistant...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics